Mitgang Charles A MD Rockville Centre, NY - 11570

Mitgang Charles A MD is categorized under Internal Medicine Practitioners in Rockville Centre, NY and active since 1984.

Mitgang Charles A MD was established in 1984, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Charles Mitgang at the company’s single location by writing to 371 Merrick Road # 302, Rockville Centre, New York NY 11570 or by phoning (516) 678-5555. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Mitgang Charles A MD
Contact Person: Charles Mitgang
Address: 371 Merrick Road # 302, Rockville Centre, New York 11570
Phone Number: (516) 678-5555
Annual Revenue (USD): $500.000 to $999.999
Founded: 1984
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Practitioners
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Mitgang Charles A MD was started in 1984 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Charles Mitgang for inquiries that concern Mitgang Charles A MD by calling the company number (516) 678-5555, as your correspondence is most welcome. Additionally, the physical location of the single location of Mitgang Charles A MD can be found at the coordinates 40.65583,-73.641701 as well as the street address 371 Merrick Road # 302 in Rockville Centre, New York 11570.

For its online presence, you may visit Mitgang Charles A MD’s website at and engage with its social media outlets through on Twitter and on Facebook.